One of the key features of Sibelius™: LactoMato is its bioavailability. In a comparative study against tomato paste, a gold standard for lycopene absorption, Sibelius™: LactoMato proved to be as bioavailable with a significantly smaller dose. The study supports a 240% increase in bioavailability compared to lycopene from fresh tomatoes.
Clinical research conducted on Sibelius™:LactoMato has shown promising results in supporting male fertility. In a three-month, double-blind, placebo-controlled, human trial conducted at the University of Sheffield, participants who were supplemented with LactoMato demonstrated significant improvements in semen quality compared to the placebo group. The study found that Sibelius™:LactoMato increased the proportion of sperm with normal morphology, as well as increasing the proportion of fast progressive sperm by 40%.
An open-label pilot study showcased a notable reduction in lipoprotein oxidation activity levels by over 70% after just two weeks of daily supplementation. Furthermore, total oxidised serum lipoproteins decreased by 46% after 8 weeks, illustrating the supplement's potential to protect the heart from oxidative damage.
In a randomised double-blind placebo-controlled parallel trial, Sibelius™: LactoMato underwent analysis for its impact on endothelial function—an essential aspect of heart health. The results revealed a 53% improvement in endothelial function in cardiovascular disease patients after 56 days of supplementation.
Sibelius™:LactoMato stands out in the men’s health market with it’s natural and clean-label formulation, clinical validation and meeting the growing consumer demand for natural solutions.
Please fill in the form below to download the Sibelius™:LactoMato key information sheet. To read our privacy policy, click here.